Until now, vascular elasticity could only be measured with large, expensive equipment in hospitals. To bring the technique closer to the patient, VitaK, has developed the “Stiffnograph”, a new, portable medical device. With the help of the StiffnoGraph, care providers are able to monitor non-invasively the stiffness of the large arteries within 2 minutes.
Are you at the base of the next breakthrough in cancer treatment? Pivot Park challenges you to think about valorisation. Present your idea to a group of both scientific and entrepreneurial experts and get the chance to present during the Pivot Oncology Conference on 21 November.
Heb je een nieuw vaccinatievraagstuk waarvan onduidelijk is of dit door het Zorginstituut (ZiN) en/of de gezondheidsraad (GR) beoordeeld moet worden? Vanaf nu kun je hiervoor met je uitgewerkte informatie bij het loketvaccinadvies terecht: loketvaccinadvies@rivm.nl.
The Health~Holland Guide (HHG) has already had a major impact on the international healthcare sector for fives years in a row. The HHG is a foreign-oriented guide in which Dutch organisations, active in the Dutch Top Sector Life Sciences & Health, are presented worldwide.
The biotechnology landscape is complex and defining a business strategy that will lead to success is challenging. Meike Sloet van Oldruitenborgh wrote an article about it, as part of her Research internship at Catalyze. The article reveals the main conclusions of a survey amongst scientific entrepreneurs in The Netherlands wherein nine successful entrepreneurs shared their inside business knowledge to empower the Dutch biotech sector.
This contest is your ticket to Boston to explore the US market. Provided you are an SME or Scale-up with an innovative product or service and have what it takes to become successful in the US. Ten winning companies will take part in a ten-day accelerator programme in the US by MIT spin-off kTeams.
Voor het zesde achtereenvolgende jaar vindt op 7 en 8 oktober het Weekend van de Wetenschap plaats. Met dit wetenschapsfestival, georganiseerd in opdracht van het Ministerie van OCW, worden de wetenschap en het wetenschappelijk onderzoek in de schijnwerpers gezet.
Zoals jullie weten staat de gezondheidszorg voor de grote uitdaging om de kwaliteit, toegankelijkheid, betaalbaarheid en de groeiende zorgvraag het hoofd te bieden. Oplossingen hiervoor kunnen deels gevonden worden in digitale innovaties.
ZCube, Research Venture of the pharmaceutical group Zambon, launches the second edition of Open Accelerator, a fast track acceleration program for life science start-up projects.
Galapagos NV (Euronext & NASDAQ: GLPG) announces a new Phase 2 study investigating filgotinib in non-infectious uveitis, being led by filgotinib collaboration partner Gilead Sciences, Inc.